Medicare Enrolled

Dr. Zeeshan Ramzan, M.D.

Gastroenterology · Fort Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1325 PENNSYLVANIA AVE STE 890, Fort Worth, TX 76104
8172507230
In practice since 2006 (19 years)
NPI: 1689689077 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ramzan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramzan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ramzan

Dr. Zeeshan Ramzan is a gastroenterology specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ramzan performed 912 Medicare services across 776 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ramzan received a total of $8,021 from 26 pharmaceutical and/or device companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ramzan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in TX $8,021 industry payments

Medicare Practice Summary

Medicare Utilization ↗
912
Medicare services
Top 29% in TX for gastroenterology
776
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~48 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
208 $61 $238
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
120 $98 $455
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
113 $51 $1,088
Endoscopic ultrasound of esophagus, stomach, or small bowel
An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope inserted through the mouth.
61 $105 $759
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $127 $500
Radiologist review of bile duct tube placement imaging
A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope.
42 $18 $108
Endoscopic removal of bile or pancreatic duct stone
A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts.
38 $127 $1,656
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
37 $94 $323
Ultrasound-guided esophageal needle biopsy
A procedure using a flexible endoscope with ultrasound to guide a needle for sampling tissue from the esophagus.
32 $148 $947
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
30 $147 $1,681
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
24 $82 $1,491
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
24 $135 $670
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
23 $39 $129
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
18 $79 $939
Endoscopic incision of pancreatic outlet
A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet.
17 $27 $1,380
Pancreatic or bile duct stent insertion
A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open.
17 $326 $1,561
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
15 $114 $1,248
Removal of large bowel tissue using flexible endoscope
A procedure to remove tissue from the large intestine using a flexible tube with a camera. The endoscope allows the provider to access and excise the tissue directly.
13 $239 $1,109
Endoscopic insertion of stomach tube
A flexible endoscope is used to guide the placement of a tube into the stomach.
11 $154 $810
Esophageal motility study
A test that evaluates the movement and function of the esophagus.
11 $50 $591
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
33.4% medium
64.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,021
Total received (2018-2024)
Avg $1,146/year across 7 years
Top 25% in TX for gastroenterology
26
Companies
82
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,066 (63.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,956 (36.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$571
2023
$544
2022
$323
2021
$65
2020
$70
2019
$798
2018
$5,650

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$5,487
Olympus Corporation of the Americas
$754
ABBVIE INC.
$493
Apollo Endosurgery US Inc
$369
Endogastric Solutions, Inc
$295
AbbVie, Inc.
$136
PFIZER INC.
$83
Janssen Biotech, Inc.
$32
Micro-tech Endoscopy USA, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Laborie Medical Technologies Corp.
$28
Amgen Inc.
$28
Ambu Inc.
$26
Ipsen Biopharmaceuticals, Inc
$26
Alcresta Therapeutics, Inc.
$22
AstraZeneca Pharmaceuticals LP
$21
Shionogi Inc
$21
Madrigal Pharmaceuticals
$19
Dynavax Technologies Corporation
$19
Lilly USA, LLC
$19
AbbVie Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
NESTLE HEALTHCARE NUTRITION INC.
$15
Aries Pharmaceuticals, Inc.
$14
INTERCEPT PHARMACEUTICALS, INC.
$14
GI Supply, Inc.
$6
Top 3 companies account for 84.0% of total payments
Associated products mentioned in payments ›
AVSOLA · Axios · Blueboost · Bylvay · CAPTIVATOR · CREON · ELEVIEW · EOHILIA · ESOPHYX · EXALT Model D · GENERAL THERAPIES · General - EndoChoice · HUMIRA · Heplisav-B · Humira · LINZESS · LesionHunter · MAVYRET · Mavyret · Mulpleta · OCALIVA · Olympus EMR & ESD Devices · OverStitch · Overstitch · RELIZORB · RESMETIROM · RINVOQ · RenovaRP · Resolution 360 Clip · SKYRIZI · STELARA · SpyGlass · THERAPIES · TREMFYA · XELJANZ · XIFAXAN · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $880 per 100 Medicare services performed
Looking for a gastroenterology specialist in Fort Worth?
Compare gastroenterologists in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
124
Per 100K population
5.8
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ramzan is a mixed practice specialist, with above-average Medicare volume (top 29% in TX), with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ramzan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Ramzan performed 208 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramzan receive payments from pharmaceutical companies?
Yes. Dr. Ramzan received a total of $8,021 from 26 companies across 82 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramzan's costs compare to other gastroenterologists in Fort Worth?
Dr. Ramzan's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramzan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →